...
首页> 外文期刊>Bioorganic and Medicinal Chemistry Letters >Fentanyl derivatives bearing aliphatic alkaneguanidinium moieties: a new series of hybrid molecules with significant binding affinity for micro-opioid receptors and I(2)-imidazoline binding sites.
【24h】

Fentanyl derivatives bearing aliphatic alkaneguanidinium moieties: a new series of hybrid molecules with significant binding affinity for micro-opioid receptors and I(2)-imidazoline binding sites.

机译:带有脂肪族烷胍基部分的芬太尼衍生物:对微阿片受体和I(2)-咪唑啉结合位点具有显着结合亲和力的一系列新的杂化分子。

获取原文
获取原文并翻译 | 示例

摘要

A new series of fentanyl derivatives [i.e., N-[1-(2-phenethyl)-4-piperidyl]-N-(guanidinoalkyl)propanamide] bearing aliphatic alkaneguanidinium moieties were prepared. Their affinities for the micro opioid receptors and for the I(2)-imidazoline binding sites (I(2)-IBS) were determined on human post-mortem prefrontal cortex membranes. All of these hybrid compounds had significant and/or very high affinity for both receptors in the nanomolar range, meaning an improvement compared to the prototype N-[1-(2-phenethyl)-4-piperidyl]-N-(guanidinopropyl)propanamide previously reported.
机译:制备了带有脂肪族链烷胍基部分的新系列的芬太尼衍生物[即,N- [1-(2-(苯乙基)-4-哌啶基] -N-(胍基烷基)丙酰胺]。他们对人阿片前额叶皮膜上的微阿片受体和I(2)-咪唑啉结合位点(I(2)-IBS)的亲和力。所有这些杂化化合物对纳摩尔范围内的两个受体都具有显着和/或非常高的亲和力,这意味着与原型N- [1-(2-(2-苯乙基)-4-哌啶基] -N-(胍基丙基)丙酰胺相比,有了改进以前的报道。

著录项

相似文献

  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号